Hester Biosciences

Price chart

Previous close

₹2,365.40

Open

₹2,306.80

Day high

₹2,376.10

Day low

₹2,297.50

Listed on NSE since 13 March 2015.

P/E (trailing)

14.58

EPS (trailing)

₹161.36

Price to book

4.28

Return on equity

34.7%

Debt to equity

0.23

Profit margin

41.1%

Volume today

1,953

Average volume

5,887

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Hester Biosciences’s results filed with NSE, consolidated (the whole group). Net profit is the share of Hester Biosciences’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Hester Biosciences’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India and internationally. It operates through two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella, lumpy skin disease, contagious bovine pleuropneumonia, and contagious caprine pleuropneumonia for cattle, buffalo, sheep, and goats; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutics, nutritional supplements, and specialised formulations to enhance animal wellness and productivity. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, grooming products, and anti-infective formulations; and healthcare products, such as immune boosters, gut health enhancers, farm hygiene, vitamins, minerals, and specialty feed supplements for critical needs comprising disease prevention, growth, and nutritional balance. Additionally, the company provides Silvectant, a hydrogen peroxide and silver nitrate solution for disinfection of poultry sheds; Hestbac, a probiotic supplement to control pathogenic bacteria; Hestflora, a combined probiotic and prebiotic formulation that supports gut health and performance; AmmoStop, a probiotic blend for odour control and respiratory comfort in poultry farms. It also offers INACTIVATED H9N2 vaccine for low pathogenic avian influenza; ICEFT RTU, a ceftiofur formulation for uterine and bacterial infections; and Inomilk Gel, an oral calcium supplement, as well as operates diagnostic labs for poultry. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Mehsana, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mehsana

Employees

483

Company website · Profile: Yahoo Finance

No headlines name Hester Biosciences in the last day or two.

• Dividend - Rs 11 Per Share

  Dividend · ex-date 14 July 2026

• Dividend - Rs 7 Per Share

  Dividend · ex-date 6 August 2025

• Dividend - Rs 6 Per Share

  Dividend · ex-date 22 August 2024

• Annual General Meeting

  Action · ex-date 22 August 2024

• Annual General Meeting/Dividend - Rs 8 Per Share

  Dividend · ex-date 13 September 2023

• Annual General Meeting/Dividend - Rs 10 Per Share

  Dividend · ex-date 11 August 2022

• Dividend - Rs 10 Per Share

  Dividend · ex-date 5 August 2021

• Dividend - Rs 6.60 Per Share

  Dividend · ex-date 27 August 2020

Source: NSE. Latest first, 8 of 18.